Vertex Pharmaceuticals Inc / Ma
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 51,578 | 0.1% | 113,768 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 87,047 | 0.2% | 222,262 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 28,669 | 0.1% | 64,396 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 60,528 | 0.1% | 124,847 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 57,069 | 0.1% | 141,717 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 172,995 | 0.3% | 371,969 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 260,451 | 0.6% | 555,665 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 357,444 | 0.9% | 855,109 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 327,028 | 0.8% | 803,726 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 283,764 | 0.8% | 816,024 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 306,188 | 0.8% | 870,076 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 319,236 | 0.9% | 1,013,223 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 262,796 | 0.8% | 910,021 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 314,215 | 0.9% | 1,085,220 | 9/30/2022 |
| 2022 Q2 | 8/12/2022 | 360,436 | 1.0% | 1,279,094 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 306,537 | 0.7% | 1,174,608 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 269,780 | 0.6% | 1,228,508 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 271,217 | 0.6% | 1,495,216 | 9/30/2021 |
| 2021 Q2 | 8/13/2021 | 11,529 | 0.0% | 57,177 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 1,870 | 0.0% | 8,701 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 420 | 0.0% | 1,776 | 12/31/2020 |
| 2020 Q3 | 11/13/2020 | 818 | 0.0% | 3,005 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 1,047 | 0.0% | 3,605 | 6/30/2020 |
| 2020 Q1 | 5/14/2020 | 867 | 0.0% | 3,643 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 1,840 | 0.0% | 8,405 | 12/31/2019 |
| 2014 Q1 | 5/15/2014 | 9,568 | 0.0% | 135,300 | 3/31/2014 |
| 2013 Q4 | 2/14/2014 | 9,793 | 0.0% | 131,800 | 12/31/2013 |